Nutshell Bio
A biotechnology company focused on life science research and human health through genome testing.
Beijing Nutshell Bio Co., Ltd. (北京果壳生物科技有限公司) is a high-tech enterprise established in 2017, focusing on the fields of life science research and human health. The founding team possesses deep expertise in the gene testing sector, with members having held key positions at notable scientific research institutions and publicly listed companies.
In the life sciences domain, the company collaborates extensively with universities, research institutes, and R&D organizations. It provides comprehensive solutions across genomics, transcriptomics, and epigenomics. The firm's service offerings include single-point detection, chip detection, and sequencing services, utilizing multiple platforms like KASP, Illumina, and ThermoFisher. For the human health sector, Nutshell Bio leverages big data platforms to innovate through machine learning and algorithmic models.
The company also operates under the name Nutshell Therapeutics, which concentrates on the discovery of allosteric drugs. It has developed a proprietary, computation-driven allosteric drug discovery platform named ALLOSTAR. This platform integrates computational modules and experimental tools based on proprietary AI algorithms and know-how in biochemistry and biophysics. It is designed to identify various drug entities, including protein activators, subtype-selective small molecules, and modulators of protein-protein interactions. In January 2022, Nutshell Therapeutics secured $20 million in a Series A funding round led by Matrix Partners China, with participation from Source Code Capital, Kunlun Capital, Northern Light Venture Capital, and Baidu Ventures. This capital is intended to advance the development of the ALLOSTAR platform and progress its allosteric drug candidates into clinical trials.
Keywords: life sciences, gene testing, multi-omics, sequencing services, drug discovery, allosteric drugs, computational biology, AI drug discovery, big data in healthcare, genomics, transcriptomics, epigenomics, molecular diagnostics, precision medicine, biotech, pharmaceutical research, drug development, protein dynamics, small molecule drugs, bioinformatics